Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atezolizumab and Cobimetinib in Advanced/Metastatic Soft Tissue Sarcomas
NCT04216953Phase 2Completed
- Sponsor
- Centre Léon Bérard
- Start
- Feb 2020
- Primary completion
- Dec 2024
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of atezolizumab, cobimetinib in soft tissue sarcoma (STS), sponsored by Centre Léon Bérard. Started Feb 2020; status: completed.
02
Drugs
atezolizumabcobimetinib
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT04216953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04216953.